Navigation Links
Amgen's Second Quarter 2013 Revenues Increased 5 Percent To $4.7 Billion And Adjusted Earnings Per Share (EPS) Increased 3 Percent To $1.89
Date:7/30/2013

THOUSAND OAKS, Calif., July 30, 2013 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced financial results for the second quarter of 2013.  Key results for the quarter include:

  • Total revenues increased 5 percent to $4,679 million, with 9 percent product sales growth driven by Enbrel® (etanercept), Neulasta® (pegfilgrastim), XGEVA® (denosumab), and Prolia® (denosumab).  Product sales included a positive adjustment of $185 million to previous estimates for managed Medicaid rebates based on recent claims experience.  Other revenues were lower by $193 million as a result of a payment from Takeda recognized in the second quarter of 2012.
  • Adjusted EPS grew 3 percent to $1.89, with higher revenues and a lower tax rate partially offset by increased Research & Development (R&D) investment.  Adjusted net income increased 1 percent to $1,444 million.
  • GAAP EPS were $1.65 compared to $1.61 and GAAP net income was $1,258 million compared to $1,266 million.
  • The Company generated approximately $1.4 billion of free cash flow.
  • "We saw solid product trends during the second quarter and are carrying good momentum into the second half," said Robert A. Bradway, chairman and chief executive officer at Amgen. "We continue to make excellent progress with our pipeline of innovative molecules and look forward to multiple data readouts in 2014, including pivotal Phase 3 data for our cholesterol-lowering agent, AMG 145, in the first quarter."Year-over-Year$Millions, except EPS and percentagesQ2 '13Q2 '12YOY ΔTotal Revenues$4,679$4,4775%Adjusted Net Income1,4441,4331%Adjusted EPS1.891.833%GAAP Net Income1,2581,266(1%)GAAP EPS$1.65$1.612%References in this release to "adjusted" measures, measures presented "on an adjusted basis" or to free cash flow refer
    '/>"/>

    SOURCE Amgen
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

    Related medicine technology :

    1. Covance Reports Second Quarter Net Revenue of $592 Million, Pro Forma EPS of $0.78 and Record Adjusted Net Orders of $776 Million
    2. Oncology remains most restrictive specialty for second year
    3. China Biologic Products to Report Second Quarter 2013 Financial Results
    4. Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2013 Second Quarter Financial Results
    5. Vanda Pharmaceuticals to Announce Second Quarter 2013 Financial Results on July 31, 2013
    6. Webcast Alert: Isis Pharmaceuticals Second Quarter 2013 Financial Results Conference Call
    7. VirtualScopics Schedules Second Quarter 2013 Earnings Announcement
    8. Luminex Corporation Reports Second Quarter 2013 Results
    9. Endo to Announce Second Quarter 2013 Financial Results on August 6, 2013
    10. Simcere Pharmaceutical Group to Announce Second Quarter 2013 Financial Results on Tuesday, August 13, 2013
    11. PDI, Inc. to Hold Second Quarter 2013 Financial Results Conference Call on Monday, August 5, 2013
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:4/1/2015)... DUBLIN , Mar. 30, 2015 Research and ... addition of the "An Introduction to the Medical ... This seminar provides a detailed introduction to the European ... which products are covered, the involvement of Notified Bodies, ... must do. It will also cover the documentation necessary ...
    (Date:4/1/2015)... 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the ... medical paper has been published describing the positive ... with severe dry eye.  The results met key ... stated that statistically significant differences in both signs ... at various time points throughout the study.  Of ...
    (Date:4/1/2015)... , April 1, 2015  Salix Pharmaceuticals, ... Pharmaceuticals International, Inc. (NYSE: VRX ) (TSX:VRX), ... the outstanding $750,000,000 aggregate principal amount of its ... U8639TAA3 (the " Notes ") pursuant to two ... $262,500,000 aggregate principal amount of the Notes, and ...
    Breaking Medicine Technology:An Introduction to the Medical Device Directives Training: London, UK - 13th, 14th, 15th of May 2015 2RegeneRx's RGN-259 Meets Key Efficacy Objectives in Phase 2 Clinical Trial in Patients with Severe Dry Eye Reported in Current Issue of Cornea 2RegeneRx's RGN-259 Meets Key Efficacy Objectives in Phase 2 Clinical Trial in Patients with Severe Dry Eye Reported in Current Issue of Cornea 3Redemption of All of Salix's Outstanding 6.00% Senior Notes due 2021 2Redemption of All of Salix's Outstanding 6.00% Senior Notes due 2021 3
    ... 15, 2010 UBM Medica announced today that it ... and iPad application which enhances physicians, clinical proficiency ... the popular DermClinic and PhotoClinic sections found on ... care clinicians, all specially selected by the Consultant ...
    ... FRANKLIN LAKES, N.J., Nov. 15, 2010 Tim Wentworth, ... Health Solutions, Inc. (NYSE: MHS ), is ... Annual Healthcare Conference on Wednesday, November 17, 2010 in ... http://www.newscom.com/cgi-bin/prnh/20100609/MEDCOLOGO) The presentation at The St. Regis ...
    Cached Medicine Technology:UBM Medica Announces PhotoClinic Mobile App for iPhone and iPad 2UBM Medica Announces PhotoClinic Mobile App for iPhone and iPad 3Medco to Present at the Lazard Capital Markets 7th Annual Healthcare Conference 2
    (Date:4/1/2015)... SCI Solutions , the health industry’s leading ... CEO Joel French will be a featured speaker at ... in Chicago, April 12-16, 2015. French will co-present “ ... Strategies ” with Northeast Georgia Health System (NGHS) on ... 38,000 healthcare industry professionals are expected at the conference, ...
    (Date:4/1/2015)... Parents of teenaged and adolescent children might want ... post discusses Teen Violence Related to Substance Abuse. As ... Awareness Month, the substance abuse treatment center has issued ... identify if there may be problems with their kids ... alcohol. , “People learn how to establish healthy relationships ...
    (Date:4/1/2015)... Tempaper has joined forces with the ... campaign that will raise critical funds to help save ... across the United States. , Throughout the month of ... will automatically receive free domestic ground shipping on ... needed progress to children and adults affected by muscular ...
    (Date:4/1/2015)... (PRWEB) April 01, 2015 Aging2.0 ... care, today announces the launch of the Aging2.0 ... senior care stakeholders and technology companies. The announcement was ... (NIC) Capital and Business Strategies Forum in San ... the new Alliance program is now open for additional ...
    (Date:4/1/2015)... Health Advocate™, Inc., the nation’s leading healthcare ... Corporation, today launched its new Health and Wellness Blog. ... the Health Advocate member website, features timely and reliable ... , “We’re pleased to introduce this new blog and ... Rosen, Executive Vice President, Health Advocate. “The blog is ...
    Breaking Medicine News(10 mins):Health News:SCI Solutions CEO Joel French and Northeast Georgia Health System to Present at HIMSS15 2Health News:SCI Solutions CEO Joel French and Northeast Georgia Health System to Present at HIMSS15 3Health News:SCI Solutions CEO Joel French and Northeast Georgia Health System to Present at HIMSS15 4Health News:Best Drug Rehabilitation Issues Toolkit for Teen Violence Related to Substance Abuse 2Health News:Tempaper and MDA Team up in the Fight Against Muscle Disease 2Health News:Tempaper and MDA Team up in the Fight Against Muscle Disease 3Health News:Aging2.0 Announces Launch of New Membership Community, Aging2.0 Alliance 2Health News:Aging2.0 Announces Launch of New Membership Community, Aging2.0 Alliance 3Health News:Aging2.0 Announces Launch of New Membership Community, Aging2.0 Alliance 4Health News:Health Advocate Launches New Health and Wellness Blog 2
    ... back we had carried a story about Wal-mart’s foray into ... pilot project which involved the lease of medical space in ... functioning at the Wal mart stores across 12 different states. ... World Health Care Congress, Leo Scott, the President and CEO ...
    ... discloses that nearly 65% of children from grade 7 to ... using artificial tanning equipments. ,The society is voicing ... under the age of 18 be prevented from tanning using ... is one of the most common forms of cancer in ...
    ... team of researchers at the John Hopkins Hospital in the US ... the PSA to detect prostate cancer.// ,The new test ... a simple blood test. ,Prostate cancer, the most ... of medicine. Physicians are unsure how to find it and when ...
    ... does not protect older women against cognitive decline, finds ... ,Identifying ways to prevent dementia is a public health ... may protect against dementia, but data from randomised studies ... US decided to test the effect of long term ...
    ... it is willing to proceed with the registration of a ... the Thai// government will halt its plans for a compulsory ... and will sell it to the Thai government for $1000 ... with the Thai government since January 2007, when plans for ...
    ... that took place last week at the Virginia Tech Many ... to formulate some// measures to avert this kind of a ... mentally ill, before they harm themselves and the others. A ... parents without the fear of infringing the privacy laws if ...
    Cached Medicine News:Health News:Artificial Tanning Causes Concern 2Health News:New blood test to detect prostate cancer 2Health News:Abbott Offers Aluvia to Thailand in Return for Compulsory Licensing Halt 2Health News:Measures Needed to Avert Another Bloodbath 2
    ... GE Medical Systems ... to see for yourself ... Centricity Physician Office - ... Practice Manager) can simplify ...
    ... 3Z slit lamp is designed to for ... ready slit lamp offers the popular horizontal ... to the ReSeeVit family of slit lamps ... market to capture clear, crisp digital images ...
    The AIA-600 II has become the new standard in benchtop immunoassay analyzers....
    ... PSA Semi-Quantitative Prostate Specific Antigen Rapid Test ... flow tests in strip and device formats ... Antigen (PSA). The tests are available with ... and all come with a 10 ng/mL ...
    Medicine Products: